PREMIER VALUE- bismuth subsalicylate tablet, chewable 
CHAIN DRUG CONSORTIUM,LLC

----------

Premier Value Bismuth Subsalicylate 30 Chewable Tablets

Active ingredient (in each tablet)

Bismuth subsalicylate 262 mg

Purpose

Anti-diarrheal/ upset stomach reliever

Uses

relieves:

travelers’ diarrhea
diarrhea
upset stomach due to overindulgence in food and drink, including:
heartburn
indigestion
nausea
gas
belching
fullness

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)
taking other salicylate products

Do not use if you have

an ulcer
a bleeding problem
bloody or black stool

Ask a doctor before use if you have

fever
mucus in the stool

Ask a doctor or pharmacist before use if you are taking any drug for

anticoagulation (thinning of the blood)
diabetes
gout
arthritis

When using this product

a temporary, but harmless, darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if
symptoms get worse or last more than 2 days
ringing in the ears or loss of hearing occurs
diarrhea lasts more than 2 days

If pregnant or breast-feeding, ask a health professional before use.

Keep Out of Reach of Children

In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222

Directions

chew completely or dissolve tablets in mouth. Do not swallow tablets whole.
adults and children 12 years and older:
2 tablets (1 dose) every 1/2 hour or 4 tablets (2 doses) every hour as needed for diarrhea
2 tablets (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)
do not exceed 8 doses (16 tablets) in 24 hours
use until diarrhea stops but not more than 2 days
children under 12 years: ask a doctor
drink plenty of clear fluids to help prevent dehydration caused by diarrhea.

Other information

each tablet contains: salicylate 102 mg
store at room temperature.
avoid excessive heat

TAMPER EVIDENT: Do not use if printed inner wrap is broken or missing.

Inactive ingredients

D&C Red No. 27 lake, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucralose.

Questions or comments?

1-866-467-2748

Principal Display

Premier Value®

NDC# 68016-124-30

COMPARE TO THE ACTIVE INGREDIENT PEPTO-BISMOL®

PINK BISMUTH

Bismuth Subsalicylate 262 mg

Provides soothing Relief for:

Upset stomach
Indigestion
Nausea
Heartburn
Diarrhea

30 CHEWABLE TABLETS

Manufactured For Your Military Exchanges

Distributed By:

Pharmacy Value Alliance, LLC

407 East Lancaster Avenue,

Wayne, PA 19087

*This product is not manufactured or distributed by The Procter & Gamble Inc., owner of the registered trademark Pepto-Bismol®.

If any reason you are not satisfied with this product, please return it to the store where purchased for a full refund.

Premier Value Pink Bismuth 30 Chewable tablets
PREMIER VALUE 
bismuth subsalicylate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-124
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
D&C RED NO. 27 (UNII: 2LRS185U6K)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SORBITOL (UNII: 506T60A25R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize17mm
FlavorImprint Code RP124
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-124-301 in 1 CARTON05/22/2019
130 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00805/22/2019
Labeler - CHAIN DRUG CONSORTIUM,LLC (101668460)

Revised: 11/2023
Document Id: 923db678-cc0c-4bbb-bdd7-2941f333be86
Set id: 3b8850e8-f9c2-4d52-aadd-8e037fabdee4
Version: 5
Effective Time: 20231103
 
CHAIN DRUG CONSORTIUM,LLC